“Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics.”, JAMA Netw Open, vol. 4, no. 5, p. e2110721, 2021.
, “Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.”, Lancet, vol. 391, no. 10118, pp. 309-318, 2018.
,